CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

Dec 2020| TBR754B| TBRC (Publisher)

Report Highlights

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

Including: By Target Antigen: CD19 Therapy; CD22 Therapy; BCMA Therapy; Others
By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others

Covering: Gilead Sciences; Novartis AG

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T Therapy market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the CAR-T therapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global CAR-T therapy market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography and segmentation by target antigen and by application.
  • Market Characteristics – The market characteristics section of the report defines and explains the CAR-T therapy market. This chapter also defines and describes products covered in the report.
  • Customer Information – This chapter covers recent customers’ trends/preferences in the global CAR-T therapy market
  • Trends And Strategies – This chapter describes the major trends shaping the global CAR-T therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the CAR-T therapy market.
  • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global CAR-T therapy market, estimated market shares and company profiles for the leading players.
  • Pipeline Analysis – This chapter covers information about the drugs currently in pipeline
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for CAR-T therapy companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

The global CAR-T therapy market is segmented into –
By Target Antigen: CD19 Therapy; CD22 Therapy; BCMA Therapy; Others
By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others

Companies Mentioned: Gilead Sciences; Novartis AG

Countries: USA, France, Germany, UK, China, India, Indonesia, Japan, South Korea, Australia, Russia, Brazil

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 2 : Global CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 3 : Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 4 : Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 5 : Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 6 : Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 7 : Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 8 : Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 9 : Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 10 : Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 11 : Asia-Pacific Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 12 : Asia Pacific Population By Age Group, 2015-2023, Thousands
  • Table 13 : Asia-Pacific Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 14 : Asia Pacific Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 15 : Asia-Pacific CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 16 : Asia-Pacific CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 17 : Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 18 : Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 19 : China Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 20 : China Population By Age Group, 2015-2023, Thousands
  • Table 21 : China Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 22 : China Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 23 : China CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 24 : China CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 25 : China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 26 : China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 27 : India Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 28 : India Population By Age Group, 2015-2023, Thousands
  • Table 29 : India Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 30 : India Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 31 : India CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 32 : India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 33 : India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 34 : Japan Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 35 : Japan Population By Age Group, 2015-2023, Thousands
  • Table 36 : Japan Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 37 : Japan Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 38 : Japan CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 39 : Japan CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 40 : Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 41 : Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 42 : Australia CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 43 : Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 44 : Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 45 : Indonesia CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 46 : Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 47 : Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 48 : South Korea CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 49 : South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 50 : South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 51 : Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 52 : Western Europe Population By Age Group, 2015-2023, Thousands
  • Table 53 : Western Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 54 : Western Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 55 : Corporate Tax Structure In Western Europe Countries, %
  • Table 56 : Western Europe CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 57 : Western Europe CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 58 : Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 59 : Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 60 : UK Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 61 : UK Population By Age Group, 2015-2023, Thousands
  • Table 62 : UK Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 63 : UK Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 64 : UK CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 65 : UK CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 66 : UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 67 : UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 68 : Germany CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 69 : Germany CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 70 : Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 71 : Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 72 : France CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 73 : France CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 74 : France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 75 : France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 76 : Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 77 : Eastern Europe Population By Age Group, 2015-2023, Thousands
  • Table 78 : Eastern Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 79 : Eastern Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 80 : Eastern Europe CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 81 : Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 82 : Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 83 : Russia CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 84 : Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 85 : Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 86 : North America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 87 : North America Population By Age Group, 2015-2023, Thousands
  • Table 88 : North America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 89 : North America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 90 : North America CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 91 : North America CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 92 : North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 93 : USA Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 94 : USA Population By Age Group, 2015-2023, Thousands
  • Table 95 : USA Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 96 : USA Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 97 : USA CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Table 98 : USA CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 99 : USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 100 : South America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 101 : South America Population By Age Group, 2015-2023, Thousands
  • Table 102 : South America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 103 : South America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 104 : South America CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 105 : South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 106 : South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 107 : Brazil CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 108 : Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 109 : Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 110 : Middle East Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 111 : Middle East Population By Age Group, 2015-2023, Thousands
  • Table 112 : Middle East Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 113 : Middle East Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 114 : Middle East CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 115 : Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 116 : Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 117 : Africa Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 118 : Africa Population By Age Group, 2015-2023, Thousands
  • Table 119 : Africa Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 120 : Africa Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 121 : Africa CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 122 : Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 123 : Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 124 : Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 125 : Gilead Sciences - Financial Performance, 2015 - 2019, $ Billion
  • Table 126 : Novartis AG - Financial Performance, 2015 - 2019, $ Billion
  • Table 127 : Pipeline Analysis Of CAR-T Cell Therapy
  • Table 128 : Global CAR-T Therapy Market Size Gain ($ Million), 2019 - 2023, By Country
  • Table 129 : Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Application, 2019 - 2023
  • Table 130 : Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Target Antigen, 2019 - 2023
  • Table 131 : CAR-T Therapy Market Data Sources
  • Figure 1 : Global CAR-T Therapy Market Segmentation By Application
  • Figure 2 : Global CAR-T Therapy Market Segmentation By Target Antigen
  • Figure 3 : Global CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 4 : Global CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 5 : Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 6 : Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 7 : Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 8 : Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 9 : Asia-Pacific CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 10 : Asia-Pacific CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 11 : Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 12 : China CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 13 : China CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 14 : China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 15 : India CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 16 : India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 17 : Japan CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 18 : Japan CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 19 : Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 20 : Australia CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 21 : Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 22 : Indonesia CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 23 : Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 24 : South Korea CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 25 : South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 26 : Western Europe CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 27 : Western Europe CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 28 : Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 29 : UK CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 30 : UK CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 31 : UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 32 : Germany CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 33 : Germany CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 34 : Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 35 : France CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 36 : France CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 37 : France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 38 : Eastern Europe CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 39 : Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 40 : Russia CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 41 : Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 42 : North America CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 43 : North America CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 44 : North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 45 : USA CAR-T Therapy Market, Historic, 2015 - 2019, $ Million
  • Figure 46 : USA CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 47 : USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 48 : South America CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 49 : South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 50 : Brazil CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 51 : Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 52 : Middle East CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 53 : Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 54 : Africa CAR-T Therapy Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 55 : Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 56 : Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 57 : Gilead Sciences - Financial Performance, 2015 - 2019, $ Billion
  • Figure 58 : Novartis AG - Financial Performance, 2015 - 2019, $ Billion
  • Figure 59 : CAR-T Therapy Market, Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020
  • Figure 60 : CAR-T Therapy Market, Number Of Active Trials By Cancer Type
  • Figure 61 : CAR-T Therapy Market, Number Of Active Trials By Cancer Type
  • Figure 62 : CAR-T Therapy Market, Global CAR-T Cell Therapy By Trial Site
  • Figure 63 : CAR-T Therapy Market, Number of Molecules In Cancer Clinical Trials, By Target

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report